FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
From - National Intelligence Report
Promoting flexibility and efficiency, the U.S. Food and Drug Administration (FDA) issued two draft guidances last week addressing oversight of…
From - National Intelligence Report
June 30, the Department of Justice (DOJ) published an Interim Final Rule in the Federal Register that has significant ramifications for enforcement under the…
From - National Intelligence Report
While the long awaited release of the PAMA rule has received a lot of attention, a significant False Claims Act (FCA) decision by the U.S. Supreme Court was also…
From - National Intelligence Report
After much lobbying, debate and delay, the Centers for Medicare & Medicaid Services (CMS) final rule implementing the Protecting Access to Medicare Act (PAMA) changes to the Clinical Laboratory Fee Schedule (CLFS) was released…